Jiangsu Hengrui Medicine

Update in progress

600276.SS (Shanghai)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Jiangsu Hengrui Pharmaceuticals Co., Ltd. is a China-based pharmaceutical company that discovers, develops, manufactures, and markets medicines to meet unmet clinical needs both domestically and internationally. Its focus areas include oncology, metabolic and cardiovascular diseases, immunology and respiratory conditions, neuroscience, pain management, infectious diseases, hematology, ophthalmology, respiratory and autoimmune disorders, among others. Founded in 1970, it is headquartered in Lianyungang, Jiangsu.

Company score

Sentiment: 0.81; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.02; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.33; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.16; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.14; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.48; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive